| Literature DB >> 36051562 |
Atina Rizkiya Choirunnisa1, Kuga Arima1, Yo Abe1, Noritaka Kagaya2, Kei Kudo3, Hikaru Suenaga3, Junko Hashimoto4, Manabu Fujie5, Noriyuki Satoh5, Kazuo Shin-Ya3, Kenichi Matsuda1,6, Toshiyuki Wakimoto1,6.
Abstract
Only a few azoxy natural products have been identified despite their intriguing biological activities. Azodyrecins D-G, four new analogs of aliphatic azoxides, were identified from two Streptomyces species by a reactivity-based screening that targets azoxy bonds. A biological activity evaluation demonstrated that the double bond in the alkyl side chain is important for the cytotoxicity of azodyrecins. An in vitro assay elucidated the tailoring step of azodyrecin biosynthesis, which is mediated by the S-adenosylmethionine (SAM)-dependent methyltransferase Ady1. This study paves the way for the targeted isolation of aliphatic azoxy natural products through a genome-mining approach and further investigations of their biosynthetic mechanisms.Entities:
Keywords: Streptomyces; biosynthesis; methyltransferase; natural azoxides; reactivity-based screening
Year: 2022 PMID: 36051562 PMCID: PMC9379638 DOI: 10.3762/bjoc.18.102
Source DB: PubMed Journal: Beilstein J Org Chem ISSN: 1860-5397 Impact factor: 2.544
Figure 1Representative natural azoxides.
Figure 2Biosynthetic gene clusters of aliphatic azoxy natural products. Conserved proteins are colored according to their functional annotations. Genes encoding homologous proteins with more than 30% amino acid sequence identities are linked.
Scheme 1N2H4-detecting colorimetric assay.
Figure 3Structures of azodyrecins (a) and new azodyrecin derivatives, azodyrecins D–G (7–10) (b). Key correlations in 2D NMR are shown.
1H (500 MHz) and 13C (125 MHz) NMR data for azodyrecin D (7), azodyrecin E (8), azodyrecin F (9), and azodyrecin G (10).a
| compound |
compound |
compound |
compound |
|||||||||
|
|
||||||||||||
| pos. | δC | δH | m, |
δC | δH | m, |
δC | δH | m, |
δC | δH | m, |
|
|
||||||||||||
| 1 | 172.7 | 172.7 | 172.9 | 170.6 | ||||||||
| 2 | 59.9 | 4.38 | q, 7.2 | 59.9 | 4.38 | q, 7.1 | 60.0 | 4.38 | q, 7.2 | 58.1 | 4.33 | q, 7.5 |
| 3 | 16.1 | 1.45 | d, 7.2 | 16.1 | 1.45 | d, 7.2 | 15.9 | 1.45 | d, 7.0 | 15.4 | 1.38 | d, 7.1 |
| 4 | 52.6 | 3.66 | s | 52.6 | 3.67 | s | 52.5 | 3.66 | s | 51.8 | 3.59 | s |
| 1’ | 70.6 | 4.21 | m | 70.6 | 4.21 | m | 70.6 | 4.22 | m | 68.9 | 4.21 | m |
| 2’ | 28.9 | 1.93 | m | 28.9 | 1.93 | m | 28.8 | 1.92 | m | 27.2 | 1.81 | m |
| 3’ | 27.3 | 1.36b | m | 27.3 | 1.37b | m | 27.2 | 1.36b | m | 25.4 | 1.20–1.30 | m |
| 4’ | 30.2 | 1.25–1.35 | m | 30.4 | 1.25–1.36 | m | 30.0 | 1.26–1.36 | m | 28.3–29.0 | 1.20–1.30 | m |
| 5’ | 29.2–31.0 | 1.25–1.35 | m | 28.4–31.3 | 1.25–1.36 | m | 30.5–30.8 | 1.26–1.36 | m | 28.3–29.0 | 1.20–1.30 | m |
| 6’ | 29.2–31.0 | 1.25–1.35 | m | 28.4–31.3 | 1.25–1.36 | m | 30.5–30.8 | 1.26–1.36 | m | 28.3–29.0 | 1.20–1.30 | m |
| 7’ | 29.2–31.0 | 1.25–1.35 | m | 28.4–31.3 | 1.25–1.36 | m | 30.5–30.8 | 1.26–1.36 | m | 28.3–29.0 | 1.20–1.30 | m |
| 8’ | 29.2–31.0 | 1.25–1.35 | m | 28.4–31.3 | 1.25–1.36 | m | 30.5–30.8 | 1.26–1.36 | m | 28.3–29.0 | 1.20–1.30 | m |
| 9’ | 29.2–31.0 | 1.25–1.35 | m | 28.4–31.3 | 1.25–1.36 | m | 30.5–30.8 | 1.26–1.36 | m | 28.3–29.0 | 1.20–1.30 | m |
| 10’ | 28.7 | 1.29b | m | 28.4–31.3 | 1.25–1.36 | m | 30.5–30.8 | 1.26–1.36 | m | 28.3–29.0 | 1.20–1.30 | m |
| 11’ | 40.4 | 1.18 | m | 37.9 | 1.31b | m | 31.0 | 1.26–1.36 | m | 28.3–29.0 | 1.20–1.30 | m |
| m | 1.10b | m | m | |||||||||
| 12’ | 29.2 | 1.53 | m | 35.8 | 1.33b | m | 28.5 | 1.28b | m | 28.3–29.0 | 1.20–1.30 | m |
| 13’ | 23.2 | 0.88 | d, 6.7 | 30.7 | 1.15 | m | 40.2 | 1.17 | m | 28.3–29.0 | 1.20–1.30 | |
| 1.25–1.36 | m | |||||||||||
| 14’ | 23.3 | 0.88 | d, 6.7 | 12.0 | 0.87 | m | 29.1 | 1.52 | m | 31.3 | 1.20–1.30 | m |
| 15’ | 19.9 | 0.86 | m | 23.0 | 0.87 | d, 6.7 | 22.1 | 1.20–1.30 | m | |||
| 16' | 23.0 | 0.87 | d, 6.7 | 13.9 | 0.85 | d, 6.6 | ||||||
aSpectra for compounds 7–9 were measured in methanol-d4 and spectrum for compound 10 was measured in DMSO-d6; bdetermined by HSQC.
Cytotoxicities of compound 2, 5, 7, and 8.
| IC50 (µM) | ||||
|
|
||||
| SKOV-3 | MESO-1 | Jurkat | P388 | |
|
|
||||
| azodyrecin B ( |
7.37 | 9.70 | 8.72 | 11.6 |
| 1’- |
8.24 | 6.70 | 3.36 | 4.72 |
| azodyrecin D ( |
>50 | 43.2 | >50 | >50 |
| azodyrecin E ( |
>50 | >50 | >50 | >50 |
Figure 4In vitro characterization of Ady1. Extracted ion chromatograms at m/z 329.3 (black) and m/z 343.3 (blue), corresponding to compound 11 and 8, respectively, are shown.
Scheme 2Proposed biosynthetic pathway of azodyrecin.
Figure 5Sequence similarity network of VlmA-like enzymes in the actinobacterial genomes in the Refseq database. Nodes are colored according to the host organism’s order. Enzymes with known biosynthetic products are colored red.